Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changhoon Yoo

Showing results (41-50 of 250) with videos related to

Pageof 25
Sort By:
Hematological Oncology|February 18, 2015
Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphomaChanghoon Yoo, Dok Hyun Yoon, Shin Kim, et al.
Cancer Research and Treatment|November 19, 2016
Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing RegimenChanghoon Yoo, Bum Jun Kim, Kyu-Pyo Kim, et al.
The Korean Journal of Internal Medicine|June 19, 2012
Toxoplasma encephalitis in an allogeneic hematopoietic stem cell transplant recipient in KoreaSoo-Kyung Park, Jong-Ki Choi, Changhoon Yoo, et al.
Journal of Cancer Research and Clinical Oncology|January 28, 2025
Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and JapanJaekyung Cheon, Shigeo Shimose, Hyung-Don Kim, et al.
Plos One|January 3, 2018
Multiplex real-time PCR using temperature sensitive primer-supplying hydrogel particles and its application for malaria species identificationJunsun Kim, Seungwon Jung, Mun Sub Byoun, et al.
Journal of Clinical Medicine|June 5, 2020
EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical TrialWon Jae Yoon, Yul Oh, Changhoon Yoo, et al.
Frontiers in Oncology|June 7, 2022
Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancreatic CancerSun Hong, Kyung Won Kim, Hyo Jung Park, et al.
Sarcoma|May 30, 2009
Angiosarcoma of the retroperitoneum: report on a patient treated with sunitinibChanghoon Yoo, Jeong-Eun Kim, Shin-Kyo Yoon, et al.
Scientific Reports|November 30, 2021
Real-world data analysis of patients with cancer of unknown primarySora Kang, Jae Ho Jeong, Shinkyo Yoon, et al.
Investigational New Drugs|October 17, 2018
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scoresInhwan Hwang, Jihoon Kang, Hei Nga Natalie Ip, et al.
Pageof 25

Showing results (41-50 of 250) with videos related to

Sort By:
Pageof 25
Hematological Oncology|February 18, 2015
Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphomaChanghoon Yoo, Dok Hyun Yoon, Shin Kim, et al.
Cancer Research and Treatment|November 19, 2016
Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing RegimenChanghoon Yoo, Bum Jun Kim, Kyu-Pyo Kim, et al.
The Korean Journal of Internal Medicine|June 19, 2012
Toxoplasma encephalitis in an allogeneic hematopoietic stem cell transplant recipient in KoreaSoo-Kyung Park, Jong-Ki Choi, Changhoon Yoo, et al.
Journal of Cancer Research and Clinical Oncology|January 28, 2025
Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and JapanJaekyung Cheon, Shigeo Shimose, Hyung-Don Kim, et al.
Plos One|January 3, 2018
Multiplex real-time PCR using temperature sensitive primer-supplying hydrogel particles and its application for malaria species identificationJunsun Kim, Seungwon Jung, Mun Sub Byoun, et al.
Journal of Clinical Medicine|June 5, 2020
EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical TrialWon Jae Yoon, Yul Oh, Changhoon Yoo, et al.
Frontiers in Oncology|June 7, 2022
Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancreatic CancerSun Hong, Kyung Won Kim, Hyo Jung Park, et al.
Sarcoma|May 30, 2009
Angiosarcoma of the retroperitoneum: report on a patient treated with sunitinibChanghoon Yoo, Jeong-Eun Kim, Shin-Kyo Yoon, et al.
Scientific Reports|November 30, 2021
Real-world data analysis of patients with cancer of unknown primarySora Kang, Jae Ho Jeong, Shinkyo Yoon, et al.
Investigational New Drugs|October 17, 2018
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scoresInhwan Hwang, Jihoon Kang, Hei Nga Natalie Ip, et al.
Pageof 25